Logo - springer
Slogan - springer

Biomedical Sciences - Pharmacology & Toxicology | Drug Discovery and Evaluation: Methods in Clinical Pharmacology

Drug Discovery and Evaluation: Methods in Clinical Pharmacology

Vogel, H.Gerhard, Maas, Jochen, Gebauer, Alexander (Eds.)

2011, XII, 564p. 138 illus..

Available Formats:
Print (Book)
Information
Print (Book)
 
$549.00

(net) price for USA

ISBN 978-3-540-89890-0

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Print + eReference
Information
Print + eReference
 
$689.00

(net) price for USA

ISBN 978-3-540-89892-4

free shipping for individuals worldwide

online orders shipping within 2-3 days.


add to marked items

eReference
Information
eReference
 
$549.00

(net) price for USA

ISBN 978-3-540-89891-7

free shipping for individuals worldwide

ready for online access


add to marked items

  • These volumes are a landmark in the continuously changing world of drugs
  • An easy-to-use, method-oriented overview on all aspects of clinical pharmacology
  • Essential reading for pharmacologists, physicians, medicinal chemists and pharmacists at research institutes and in industry
  • Of use for governmental institutions and committees working on official guidelines for drug evaluation worldwide

Drug Discovery and Evaluation has become a more and more difficult, expensive and time-consuming process. The effect of a new compound has to be detected by in vitro and in vivo methods of pharmacology. The activity spectrum and the potency compared to existing drugs have to be determined.

As these processes can be divided up stepwise we have designed a book series "Drug Discovery and Evaluation" in the form of a recommendation document. The methods to detect drug targets are described in the first volume of this series "Pharmacological Assays" comprising classical methods as well as new technologies. Before going to man, the most suitable compound has to be selected by pharmacokinetic studies and experiments in toxicology. These preclinical methods are described in the second volume „Safety and Pharmacokinetic Assays". Only then are first studies in human beings allowed. Special rules are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: „Methods in Clinical Pharmacology".

Content Level » Research

Related subjects » Pharmacology & Toxicology

Table of contents 

A. Clinical Pharmacokinetics.- Single Dose studies incl. Dose finding by allometry.- Multiple Dose studies.- Dose linearity and Proportionality.- Special Populations.- The hADME-study (incl. Dosimetry) and its results.- Synthesis of radiolabelled compounds for clinical studies.- Regulatory Guidelines regarding Metabolite identification and testing.- Drug-Drug interaction studies.- In vitro in vivo correlation for drug-drug interactions.- Specific studies for formulation development.- Absolute and relative bioavailability.- Bioequivalence.- PopKin approaches.- Bioanalysis of clinical studies.- Biomarker, surrogate parameters and clinical endpoints. -Toxicokinetics and safety ratios.- Relevance of transporters in clinical studies.- In vitro in vivo correlation for transporters.- Specifities of oncology studies.- Pharmacogenomics and its influence on Pharmacokinetics.- PK/PD approaches; B. Human Studies in Clinical Pharmacology: Methodologies of PD assessment - Scales.- Methodologies of PD assessment - BioStat. -Methodologies of Safety assessment.- Pharmacodynamic Evaluation.- Respiratory System.- Pharmacodynamic Evaluation.- Cardiovascular Methodologies.- Pharmacodynamic Evaluation.- CNS.- Pharmacodynamic Evaluation.- Diabetes Methodologies.- Pharmacodynamic Evaluation.- Metabolism/Lipids.- Pharmacodynamic Evaluation.- Inflammation/Immunology.- Pharmacodynamic Evaluation.- Pain.- Pharmacodynamic Evaluation.- Endocrinology.- Pharmacodynamic Evaluation.- Anesthetics.- Pharmacodynamic Evaluation.- Dermatology.- Pharmacodynamic Evaluation.- Oncology.- Pharmacodynamic Evaluation.- Antibiotics.- Pharmacodynamic DD interaction.- Pharmacogenomics: Pharmacodymanic relevance; C. Regulations: Regulatory requirements in Clinical Pharmacology.

Distribution rights 

Distribution rights for India: CBS Publishers, New Delhi, India

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Pharmacology / Toxicology.